Innate immune factors associated with HIV-1 transmission

Current Opinion in HIV and AIDS

Volumn 6, Issue 5, 2011, Pages 341-347

  Pollakis, Georgios ^a   Stax, Martijn J ^a   Paxton, William A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HIV 1 transmission; innate extracellular factors; innate immune cells

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GALECTIN 3; LANGERIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MUCIN 6; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; VIRUS GLYCOPROTEIN;

BREAST MILK; CD4+ T LYMPHOCYTE; DENDRITIC CELL; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOMODULATION; INFECTION RISK; INNATE IMMUNITY; LANGERHANS CELL; MACROPHAGE; MUCUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; SPERM; VAGINA SECRETION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL;

EID: 80051719241     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283499e11     Document Type: Review

References (89)

1. Lim SG, Condez A, Lee CA, et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993; 92:448-454. (Pubitemid 23183754)
2. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1:23-30.
3. Venkatesh KK, van der Straten A, Cheng H, et al. The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study. Int J STD AIDS 2011; 22:218-224.
4. Cunningham AL, Carbone F, Geijtenbeek TB. Langerhans cells and viral immunity. Eur J Immunol 2008; 38:2377-2385.
5. Kawamura T, Kurtz SE, Blauvelt A, et al. The role of Langerhans cells in the sexual transmission of HIV. J Dermatological Science 2005; 40:147-155. (Pubitemid 41728962)
6. de Witte L, Nabatov A, Geijtenbeek TB. Distinct roles for DC-SIGN+dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 2008; 14:12-19.
7. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811. (Pubitemid 30365397)
8. Plzák J, Holíková Z, Smetana K Jr, et al. The role of dendritic cells in the pharynx. Eur Arch Otorhinolaryngol 2003; 260:266-272. (Pubitemid 36718278)
9. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5:953-964. (Pubitemid 41746764)
10. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol 2006; 18:49-53. (Pubitemid 43049647)
11. Lassmann H, Schmied M, Vass K, et al. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7:19-24.
12. Cassol E, Cassetta L, Alfano M, et al. Macrophage polarization and HIV-1 infection. J Leukoc Biol 2010; 87:599-608.
13. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol 2011; 89:785-795.
14. Yao H, Yang Y, Kim KJ, et al. Molecular mechanisms involving sigma receptormediated induction of MCP-1: implication for increased monocyte transmigration. Blood 2010; 115:4951-4962.
15. Madsen J, Mollenhauer J, Holmskov U. Review: Gp-340/DMBT1 in mucosal innate immunity. Innate Immun 2010; 16:160-167.
16. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans' cells. Nature Rev Immunol 2002; 2:77-84. (Pubitemid 37323231)
17. Holíková Z, Hercogová J, Plzák J, et al. Dendritic cells and their role in skininduced immune responses. JEADV 2001; 15:116-120. (Pubitemid 32851209)
18. Jiang W, Swiggard WJ, Heuffer M, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995; 375:151-155.
19. Valladeau J, Duvert-Frances V, Pin JJ, et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol 2001; 167:5767-5774. (Pubitemid 33062768)
20. Plzák J, Holíková Z, Smetana K Jr, et al. The role of dendritic cells in the pharynx. Eur Arch Otorhinolaryngol 2003; 260:266-272. (Pubitemid 36718278)
21. van der Vlist M, van der Aar AMG, Gringhuis SI, Geijtenbeek TBH. Innate signalling in HIV-1 infection of dendritic cells. Curr Opin HIV AIDS. 2011; 6.
22. Valladeau J, Ravel O, Dezutter-Dambuyant C. Langerin: a novel C-type lectin specific to Langerhans' cell, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12:71-81. (Pubitemid 30069216)
23. Plzák J, Smetana K Jr, Hrdliciková E, et al. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol 2001; 19:59-64.
24. Smetana K, Holíková Z, Klubal R, et al. Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells. J Leukoc Biol 1999; 66:644-649. (Pubitemid 29489892)
25. Kaplan DH, Kissenpfenning A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008; 38:2369-2376.
26. He Y, Zhang J, Donahue C, et al. Skin-derived dendritic cells induce potent CD8(1) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 2006; 24:643-656.
27. Mayerova D, Parke EA, Bursch LS, et al. Langerhans cells activate naive selfantigen-specific CD8 T cells in the steady state. Immunity 2004; 21:391-400. (Pubitemid 39208340)
28. Trumpfheller C, Park CG, Finke J, et al. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int Immunol 2003; 15:289-298. (Pubitemid 36267121)
29. McDonald D, Wu L, Bohks SM, et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003; 300:1295-1297. (Pubitemid 36618241)
30. Arrighi JF, Pion M, Garcia E, et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 2004; 200:1279-1288. (Pubitemid 39552569)
31. van der Vlist M, Geijtenbeek TB. Langerin functions as an antiviral receptor on Langerhans cells. Immunol Cell Biol 2010; 88:410-415.
32. Fahrbach KM, Barry SM, Ayehunie S, et al. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 2007; 81:6858-6868. (Pubitemid 46986622)
33. Kawamura T, Cohen SS, Borris DL, et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 2000; 192:1491-1500.
34. Zaitseva M, Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med 1997; 3:1369-1375. (Pubitemid 28011037)
35. Reece JC, Handley AJ, Anstee EJ, et al. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 1998; 187:1623-1631. (Pubitemid 28235103)
36. Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996; 183:215-225. (Pubitemid 26028761)
37. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000; 74:6087-6095. (Pubitemid 30412980)
38. Cobos-Jiménez V, Booiman T, Hamann J, Kootstra NA. V Macrophages and HIV-1 Curr Opin HIV AIDS. 2011; 6.
39. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-1038.
40. Benlahrech A, Patterson S. HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells. Curr Opin HIV AIDS. 2011; 6.
41. Borrow P. Innate immunity in acute HIV-1 infection. Curr Opin HIV AIDS. 2011; 6.
42. Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202 (Suppl 2):S297-S301.
43. Derby N, Martinelli E, Robbiani M. Myeloid DCs in HIV Infection Curr Opin HIV AIDS. 2011; 6.
44. Gougeon M-L, Bras M. Natural killer cells, dendritic cells and the alarmin HMGB1: a dangerous trio in HIV-1 infection? Curr Opin HIV AIDS. 2011; 6.
45. Smed-Sörensen A, Loré K. Dendritic cells in the interface of innate and adaptive immunity to HIV-1. Curr Opin HIV AIDS. 2011; 6.
46. Ellegard R, Shankar EM, Larsson M. Targetting HIV-1 innate immune responses therapeutically. Curr Opin HIV AIDS. 2011; 6.
47. Choi WT. Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. Exp Biol Med 2011; 236:637-647.
48. Lajoie J, Poudrier J, Loembe MM, et al. Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from Benin. J Clin Immunol 2010; 30:90-98.
49. Berkhout B, van Wamel JL, Beljaars L, et al. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res 2002; 55:341-355. (Pubitemid 34718133)
50. Levinson P, Kaul R, Kimani J, et al. HIV Study Group. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009; 23:309-317.
51. Quinones-Mateu ME, Lederman MM, Feng Z, et al. Human epithelial betadefensins2 and 3 inhibit HIV-1 replication. AIDS 2003; 17:F39-F48. (Pubitemid 38147012)
52. Chang TL, Vargas J Jr, DelPortillo A, et al. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest 2005; 115:765-773. (Pubitemid 40322253)
53. Bergman P, Walter-Jallow L, Broliden K, et al. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 2007; 5:410-415. (Pubitemid 47040482)
54. Zheng Y, Niyonsaba F, Ushio H, et al. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 2007; 157:1124-1131. (Pubitemid 350115677)
55. Levinson P, Kaul R, Kimani J, et al. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009; 23:309-317.
56. Kim KA, Yolamanova M, Zirafi O, et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010; 7:55.
57. Olsen JS, Brown C, Capule CC, et al. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)-and semen-mediated enhancement of HIV-1 infection. J Biol Chem 2010; 285: 35488-35496.
58. Ceballos A, Remes Lenicov F, Sabatté J, et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med 2009; 206:2717-2733.
59. van Montfort T, Nabatov A, Geijtenbeek TBH, et al. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol 2007; 177:3177-3185. (Pubitemid 46333200)
60. van Montfort T, Thomas AAAM, Pollakis G, et al. Dendritic cells preferentially transmit CXCR4-using HIV-1 variants to CD4+ T lymphocytes in trans. J Virol 2008; 82:7886-7896.
61. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986; 83:6692-6696. (Pubitemid 16002300)
62. Ma G, Greenwell-Wild T, Lei K, et al. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 2004; 200:1337-1346. (Pubitemid 39552574)
63. Guerrieri D, Tateosian NL, MaffíaPCet al. Serine leucocyte proteinase inhibitortreated monocyte inhibits human CD4+ lymphocyte proliferation. Immunology 2011. [Epub ahead of print]. DOI:1111/j.1365-2567. 2011.03451.x
64. Madsen J, Mollenhauer J, Holmskov U. Review: Gp-340/DMBT1 in mucosal innate immunity. Innate Immun 2010; 16:160-167.
65. Wu Z, Lee S, Abrams W, et al. The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection. AIDS Res Hum Retroviruses 2006; 22:508-515.
66. Stoddard E, Ni H, Cannon G, et al. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol 2009; 83:8596-8603.
67. Naarding MA, Dirac AM, Ludwig IS, et al. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells. Antimicrob Agents Chemother 2006; 50:3367-3374. (Pubitemid 44527512)
68. Stax MJ, Naarding MA, Tanck MWT, et al. Binding of human milk to pathogen receptor DC-SIGN varies with bile salt-stimulated lipase (BSSL) gene polymorphism. PLoS ONE 2011; 6:e17316.
69. Panicot-Dubois L, Thomas GM, Furie BC, et al. Bile salt-dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans. J Clin Invest 2007; 117:3708-3719. (Pubitemid 350224082)
70. Habte HH, Mall AS, de Beer C, et al. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of human immunodeficiency virus type 1 in an inhibition assay. Virol J 2006; 3:99.
71. Stax MJ, van Montfort T, Sprenger RR, et al. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4+ T-lymphocytes. Virology 2009; 391:203-211.
72. Saeland E, de Jong MA, Nabatov AA, et al. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 2009; 46:2309-2316.
73. Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009; 87 (13 Suppl): 26-34.
74. Ruvoë n-Clouet N, Mas E, Marionneau S, et al. Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem J 2006; 393:627-634. (Pubitemid 43163803)
75. Borén T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-1895. (Pubitemid 24041864)
76. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320:773-777. (Pubitemid 19093544)
77. Nguyen TV, JanssenMJr, Gritters P, et al. Short mucin 6 alleles are associated with H pylori infection. World J Gastroenterol 2006; 12:6021-6025. (Pubitemid 44608482)
78. Moulds JM, Nowicki S, Moulds JJ, et al. Human blood groups: incidental receptors for viruses and bacteria. Transfusion 1996; 36:362-374. (Pubitemid 26141066)
79. Fumagalli M, Cagliani R, Pozzoli U, et al. Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res 2009; 19:199-212.
80. Branch DR. Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol 2010; 17:558-564.
81. Sobieszczyk ME, Lingappa J, McElrath JM. Host genetic polymorphisms associated with innate immune factors and HIV-1. Curr Opin HIV AIDS. 2011; 6.
82. Malim MH, Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 2008; 3:388-398. (Pubitemid 351784365)
83. Berger A, Mü nk C, Schweizer M, et al. Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J Biol Chem 2010; 285:12248-12254.
84. Evans DT, Serra-Moreno R, Singh RK, et al. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 2010; 18:388-396.
85. Bosinger SE, Sodora DL, Silvestri G. Generalized immune activation and innate immune responses in SIV infection. Curr Opin HIV AIDS. 2011; 6.
86. Hawes SE, Sow PS, Stern JE, et al. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 2008; 22:2517-2525.
87. Gottlieb GS, Hawes SE, Agne HD, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 2006; 20:895-900. (Pubitemid 43731572)
88. Berger A, Münk C, Schweizer M, et al. Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J Biol Chem 2010; 16:12248-12254.
89. Cavaleiro R, Baptista AP, Soares RS, et al. Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. PLoS Pathog 2009; 5:e1000667.